Author:
El Bouzidi Kate,Jose Sophie,Phillips Andrew N.,Pozniak Anton,Ustianowski Andrew,Gompels Mark,Winston Alan,Schaap Ab,Dunn David T.,Sabin Caroline A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference29 articles.
1. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (updated November 2013);Williams;HIV Med,2014
2. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015;Churchill;HIV Med,2016
3. Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses;Lennox;J Acquir Immune Defic Syndr,2010
4. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial;Lennox;Ann Intern Med,2014
5. A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 results;Zolopa;J Acquir Immune Defic Syndr,2013
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献